Specimen self-collection for SARS-CoV-2 testing: Patient performance and preferences-Atlanta, Georgia, August-October 2020

PLoS One. 2022 Mar 9;17(3):e0264085. doi: 10.1371/journal.pone.0264085. eCollection 2022.

Abstract

Self-collected specimens can expand access to SARS-CoV-2 testing. At a large inner-city hospital 1,082 participants self-collected saliva and anterior nasal swab (ANS) samples before healthcare workers collected nasopharyngeal swab (NPS) samples on the same day. To characterize patient preferences for self-collection, this investigation explored ability, comfort, and ease of ANS and saliva self-collection for SARS-CoV-2 testing along with associated patient characteristics, including medical history and symptoms of COVID-19. With nearly all participants successfully submitting a specimen, favorable ratings from most participants (at least >79% in ease and comfort), and equivocal preference between saliva and ANS, self-collection is a viable SARS-CoV-2 testing option.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • COVID-19 / diagnosis*
  • COVID-19 / virology
  • COVID-19 Testing
  • Female
  • Georgia
  • Humans
  • Male
  • Middle Aged
  • Nasopharynx / virology
  • RNA, Viral / analysis
  • RNA, Viral / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / isolation & purification
  • Saliva / virology
  • Specimen Handling / methods*
  • Young Adult

Substances

  • RNA, Viral